Skye Bioscience Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: SKYE
Share price (8/20/26): $0.28
Market cap (8/20/26): $9.932 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from DEFA14A 220 pages Transaction Agreement by and Between Redx Pharma Limited and Skye Bioscience, Inc. Dated as of August 14, 2026

from 8-K 220 pages Transaction Agreement by and Between Redx Pharma Limited and Skye Bioscience, Inc. Dated as of August 14, 2026

from 10-K 79 pages Agreement and Plan of Merger and Reorganization by and Among: Skye Bioscience, Inc., a Nevada Corporation; Aquila Merger Sub, Inc., a Delaware Corporation; and Bird Rock Bio, Inc., a Delaware Corporation Dated as of August 15, 2023

from 8-K 89 pages Plan of reorganization, merger, acquisition or similar

from 8-K 120 pages Arrangement Agreement Between Skye Bioscience, Inc. and Emerald Health Therapeutics, Inc. May 11, 2022

from SC 13D/A 1 page Form of Amendment No. 1 to Promissory Note

from 8-K 21 pages Agreement and Plan of Merger